MTHFR and metabolic dysfunction-associated steatotic liver disease: Interestingly, NAFLD patients were previously shown to present with increased plasma homocysteine (Hcy), along with MTHFR C677T, when compared with healthy controls, further highlighting the involvement of MTHFR in the disease onset and progression [31,34].